ATE113056T1 - Künstliche rezeptor-analoge. - Google Patents

Künstliche rezeptor-analoge.

Info

Publication number: ATE113056T1
Authority: AT; Austria
Prior art keywords: pct; galabiose; artificial receptor; sec; receptor analogues
Prior art date: 1988-08-12

Application number

AT89909545T

Other languages

English (en)

Inventor

Hans Goeran Magnusson

Jan Olof Kihlberg

Original Assignee

Symbicom Ab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1988-08-12

Filing date

1989-08-11

Publication date

1994-11-15

1989-08-11 Application filed by Symbicom Ab filed Critical Symbicom Ab

1994-11-15 Application granted granted Critical

1994-11-15 Publication of ATE113056T1 publication Critical patent/ATE113056T1/de

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/04—Acyclic radicals, not substituted by cyclic structures attached to an oxygen atom of the saccharide radical
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
- G01N33/56911—Bacteria

Landscapes

Chemical & Material Sciences (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Molecular Biology (AREA)
General Health & Medical Sciences (AREA)
Biochemistry (AREA)
Biotechnology (AREA)
Genetics & Genomics (AREA)
Immunology (AREA)
Crystallography & Structural Chemistry (AREA)
Urology & Nephrology (AREA)
Biomedical Technology (AREA)
Hematology (AREA)
Medicinal Chemistry (AREA)
Virology (AREA)
Cell Biology (AREA)
Microbiology (AREA)
Tropical Medicine & Parasitology (AREA)
Food Science & Technology (AREA)
Physics & Mathematics (AREA)
Analytical Chemistry (AREA)
General Physics & Mathematics (AREA)
Pathology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Saccharide Compounds (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Prostheses (AREA)

AT89909545T 1988-08-12 1989-08-11 Künstliche rezeptor-analoge. ATE113056T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
DK455088A DK455088D0 (da)	1988-08-12	1988-08-12	Syntetiske receptoranaloger

Publications (1)

Publication Number	Publication Date
ATE113056T1 true ATE113056T1 (de)	1994-11-15

Family

ID=8134551

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT89909545T ATE113056T1 (de)	1988-08-12	1989-08-11	Künstliche rezeptor-analoge.

Country Status (12)

Country	Link
US (1)	US5474986A (de)
EP (1)	EP0428605B1 (de)
JP (1)	JPH04506509A (de)
KR (1)	KR900701807A (de)
AT (1)	ATE113056T1 (de)
AU (1)	AU634976B2 (de)
CA (1)	CA1332234C (de)
DE (1)	DE68918944T2 (de)
DK (1)	DK455088D0 (de)
FI (1)	FI93016C (de)
IL (1)	IL91269A (de)
WO (1)	WO1990001488A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE4119472A1 (de) *	1991-06-13	1992-12-17	Merck Patent Gmbh	Verfahren zur stereoselektiven herstellung von gal-(alpha)(1-3)/gal-(beta)(1-4)/glcnac-trisacchariden und von neuen (beta)(1-3)-verknuepften oligolactosaminen ueber neue partiell alkylierte glykale
US5409902A (en) *	1991-12-31	1995-04-25	Lever Brothers Company	Oral hygiene compositions containing glyceroglycolipids as antiplaque compounds
EP0601417A3 (de) *	1992-12-11	1998-07-01	Hoechst Aktiengesellschaft	Physiologisch verträglicher und physiologisch abbaubarer, Kohlenhydratrezeptorblocker auf Polymerbasis, ein Verfahren zu seiner Herstellung und seine Verwendung
TW307775B (en) *	1994-02-15	1997-06-11	Novartis Erfind Verwalt Gmbh	Unsaturated carbohydrate derivatives, polymers thereof and their use
US6596707B2 (en) *	2001-05-24	2003-07-22	Abbott Laboratories	Monovalent saccharides and uses thereof
US7790010B2 (en) *	2002-12-20	2010-09-07	University Of Maryland, College Park	Spatially selective deposition of polysaccharide layer onto patterned template
EP2497478A3 (de) *	2003-12-05	2012-11-07	Children's Hospital Medical Center	Oligosaccarid-Zusammensetzungen und ihre Verwendung bei der Behandlung von Infektionen
EP2631650B1 (de)	2007-09-07	2015-04-22	Children's Hospital Medical Center	Zusammensetzung mit alpha-1,2 Fukosyl Glykanen für die Behandlung von Magen-Darmerkrankungen
ES2651067T3 (es)	2009-07-06	2018-01-24	Children's Hospital Medical Center	Inhibición de la inflamación con oligosacáridos de la leche
JP6187893B2 (ja) *	2011-07-08	2017-08-30	群栄化学工業株式会社	保湿剤の製造方法
WO2014130789A1 (en)	2013-02-21	2014-08-28	Children's Hospital Medical Center	Use of glycans and glycosyltransferases for diagnosing/monitoring inflammatory bowel disease
EP3288389A4 (de)	2015-04-28	2018-10-10	Children's Hospital Medical Center	Verwendung von oligosaccharidzusammensetzungen zur verstärkung der gewichtszunahme
CN111566117A (zh)	2017-12-29	2020-08-21	糖模拟物有限公司	E-选择蛋白和半乳凝素-3的异双功能抑制剂
US11845771B2 (en)	2018-12-27	2023-12-19	Glycomimetics, Inc.	Heterobifunctional inhibitors of E-selectin and galectin-3
AU2019416330A1 (en)	2018-12-27	2021-07-01	Glycomimetics, Inc.	Galectin-3 inhibiting c-glycosides

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SE8001748L (sv) *	1980-03-05	1981-09-06	Kaellenius Gunilla	Kompositioner for terapeutisk eller diagnostisk anvendning jemte forfarande for terapeutik
EP0089940A1 (de) *	1982-03-23	1983-09-28	BioCarp AB	Oligosaccharide umfassende Zusammensetzung für therapeutische oder diagnostische Verwendung
SE8203925D0 (sv) *	1982-06-23	1982-06-23	Svenska Sockerfabriks Ab	New and novel glycosides, glycoconjugates and processes for their preparation
SE8304007D0 (sv) *	1983-07-15	1983-07-15	Karlsson Karl Anders	Forening och komposition for terapeutisk eller diagnostisk anvendning samt forfarande for terapeutisk behandling
SE8406626D0 (sv) *	1984-12-27	1984-12-27	Bio Carb Ab	Forening och komposition for terapeutisk eller diagnostisk anvendning jemte anvendning av sadan forening och komposition for terapeutisk behandling och isolering av shigatoxin
DK17685D0 (da) *	1985-01-14	1985-01-14	Hans Goeran Magnusson	Glycosidderivater

1988
- 1988-08-12 DK DK455088A patent/DK455088D0/da not_active Application Discontinuation
1989
- 1989-08-09 IL IL9126989A patent/IL91269A/en not_active IP Right Cessation
- 1989-08-11 AU AU40749/89A patent/AU634976B2/en not_active Ceased
- 1989-08-11 JP JP1508951A patent/JPH04506509A/ja active Pending
- 1989-08-11 EP EP89909545A patent/EP0428605B1/de not_active Expired - Lifetime
- 1989-08-11 WO PCT/DK1989/000192 patent/WO1990001488A1/en active IP Right Grant
- 1989-08-11 KR KR1019900700766A patent/KR900701807A/ko not_active Application Discontinuation
- 1989-08-11 CA CA000608146A patent/CA1332234C/en not_active Expired - Fee Related
- 1989-08-11 US US07/689,077 patent/US5474986A/en not_active Expired - Fee Related
- 1989-08-11 AT AT89909545T patent/ATE113056T1/de not_active IP Right Cessation
- 1989-08-11 DE DE68918944T patent/DE68918944T2/de not_active Expired - Fee Related
1991
- 1991-02-11 FI FI910653A patent/FI93016C/fi not_active IP Right Cessation

Also Published As

Publication number	Publication date
FI910653A0 (fi)	1991-02-11
JPH04506509A (ja)	1992-11-12
AU4074989A (en)	1990-03-05
FI93016C (fi)	1995-02-10
KR900701807A (ko)	1990-12-04
EP0428605B1 (de)	1994-10-19
IL91269A (en)	1994-11-11
US5474986A (en)	1995-12-12
WO1990001488A1 (en)	1990-02-22
CA1332234C (en)	1994-10-04
FI93016B (fi)	1994-10-31
DE68918944D1 (de)	1994-11-24
EP0428605A1 (de)	1991-05-29
DK455088D0 (da)	1988-08-12
DE68918944T2 (de)	1995-05-11
AU634976B2 (en)	1993-03-11

Publication	Publication Date	Title
ATE113056T1 (de)	1994-11-15	Künstliche rezeptor-analoge.
ES2131496T3 (es)	1999-08-01	Mejoras relativas a derivados glicopeptidicos.
DK0507933T3 (da)	1996-06-17	Nær-vaskulariserende implantationsmateriale
DK0611522T3 (da)	1997-01-27	Synergistiske mikrobicide sammensætninger
NO891909D0 (no)	1989-05-10	Implantat for brytningskorreksjon i et oeyes forkammer.
SE8503680L (sv)	1986-02-02	Indolderivat
YU48666B (sh)	1999-06-15	Mometason furoat monohidrat i postupak za njegovo dobijanje
NO306609B1 (no)	1999-11-29	I det vesentlige sfaerisk vateritt og fremgangsmåte for fremstilling derav
ES2026576T3 (es)	1992-05-01	Un metodo para controlar la distribucion epimera en la preparacion de 16,17-acetales o cetales de derivados de pregnano.
ES2080140T3 (es)	1996-02-01	Derivados de eritromicina.
NO953353D0 (no)	1995-08-25	Xantinderivater som adenosin-A -reseptorantagonister
CS9100438A2 (en)	1991-09-15	New derivative of beta-phenylisoserine, method of its preparation and its application
ATE141796T1 (de)	1996-09-15	2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ES2028871T3 (es)	1992-07-16	Un procedimiento para la preparacion de un glicosido de antraciclina. .
NZ234451A (en)	1991-08-27	Benzofuran-substituted 2-imidazoline derivatives and pharmaceutical compositions
GR3005566T3 (de)	1993-06-07
ES2119814T3 (es)	1998-10-16	Metodo para la separacion de mezclas de gibberelinas.
DE69102514D1 (de)	1994-07-21	Bestandteil eines künstlichen gliedes.
AU1786988A (en)	1988-12-21	Isoxazoles with nootropic activity
엄인웅 et al.	1991	Open reduction of fractured mandibular condyles: overview
ATE100696T1 (de)	1994-02-15	Endoprothese.
IT210946Z2 (it)	1989-01-30	Attacco ammortizzato per protesi dentaria.
NO974687D0 (no)	1997-10-10	Kondenserte <beta>-carboliner
MX9802268A (es)	1998-08-30	Nuevos derivados de la substancia pf1022 de ciclodepsipeptido.
IT1214294B (it)	1990-01-10	Protesi anatomica femorale perfezionata, applicabile senza cementazione.

Legal Events

Date	Code	Title	Description
1995-05-15	UEP	Publication of translation of european patent specification
1998-05-15	REN	Ceased due to non-payment of the annual fee